Dyspnea: Clinical Trials

6 trials for Dyspnea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated, 1 unknown, 1 withdrawn. 6 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 16Completed 3, Terminated 1, Unknown 1, Withdrawn 1

Follow Dyspnea: new trials by email Literature Review of Dyspnea trials Research Report on Dyspnea

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Post-Acute Sequelae of Coronavirus-19 (COVID-19) With Dyspnea on Exertion And Associated TaChycardia TrEatment Study
Metoprolol Succinate - Tachycardia, Dyspnea
Early Phase 1TerminatedHackensack Meridian Health142022-03-232024-12-03
The Effect of Inhaled Nitric Oxide on Deadspace in COPD
Nitric Oxide, Placebo - Chronic Obstructive Pulmonary Disease
Early Phase 1CompletedDr. Denis O'Donnell132021-09-012024-04-03
S-Nitrosylation Therapy of COVID-19
SNO, Nitrogen gas - SARS-CoV2 Infection, Covid19
Early Phase 1WithdrawnJames Reynolds2021-08-052025-05-07
Understanding the Importance of Plasticity in the Brain Mechanisms of Dyspnoea Perception
d-cycloserine, placebo - Chronic Obstructive Pulmonary Disease
Early Phase 1UnknownUniversity of Oxford902013-11-012018-10-12
Inhaled Ondansetron & Dyspnea
Ondansetron, Placebo - Dyspnea
Early Phase 1CompletedMcGill University302013-06-012015-08-26
Inhaled Fentanyl Citrate & Dyspnea
Fentanyl Citrate, CWS, Placebo - Dyspnea
Early Phase 1CompletedMcGill University142013-06-012017-02-14

Narrower conditions

Motor Activity (3)  ·  COVID-19 (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Post-Acute COVID-19 Syndrome (1)  ·  Respiratory Insufficiency (1)  ·  Tachycardia (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (6)  ·  Respiration Disorders (6)  ·  Respiratory Tract Diseases (6)  ·  Signs and Symptoms (6)  ·  Signs and Symptoms, Respiratory (6)  ·  Lung Diseases (4)  ·  Behavior (3)  ·  Chronic Disease (3)  ·  Disease Attributes (3)  ·  Pathologic Processes (3)  ·  Coronaviridae Infections (2)  ·  Coronavirus Infections (2)  ·  Infections (2)  ·  Lung Diseases, Obstructive (2)  ·  Nidovirales Infections (2)

Interventions

Cycloserine (1)  ·  Fentanyl (1)  ·  Metoprolol (1)  ·  Nitric Oxide (1)  ·  Nitrogen (1)  ·  Ondansetron (1)

Sponsors

McGill University (2)  ·  Dr. Denis O'Donnell (1)  ·  Hackensack Meridian Health (1)  ·  James Reynolds (1)  ·  University of Oxford (1)

Countries

Canada (3)  ·  United States (2)  ·  United Kingdom (1)

Top investigators

Dennis Jensen, Ph.D. (2)  ·  David Landers, MD (1)  ·  Denis E O'Donnell, MD (1)  ·  Kyle TS Pattinson, BM DPhil FRCA (1)  ·  Robert Schilz, DO, PhD (1)

Results publications

PMID 26031762, PMID 36572534, PMID 37020840, PMID 40455920